HK1194005A1 - 腎上腺功能不全的治療 - Google Patents

腎上腺功能不全的治療

Info

Publication number
HK1194005A1
HK1194005A1 HK14107519.1A HK14107519A HK1194005A1 HK 1194005 A1 HK1194005 A1 HK 1194005A1 HK 14107519 A HK14107519 A HK 14107519A HK 1194005 A1 HK1194005 A1 HK 1194005A1
Authority
HK
Hong Kong
Prior art keywords
treatment
adrenal insufficiency
adrenal
insufficiency
Prior art date
Application number
HK14107519.1A
Other languages
English (en)
Inventor
Hiep Huatan
Richard Ross
Martin Whitaker
Original Assignee
Diurnal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diurnal Ltd filed Critical Diurnal Ltd
Publication of HK1194005A1 publication Critical patent/HK1194005A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
HK14107519.1A 2011-11-19 2014-07-23 腎上腺功能不全的治療 HK1194005A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1119985.8A GB201119985D0 (en) 2011-11-19 2011-11-19 Treatment of adrenal insufficiency
PCT/GB2012/052864 WO2013072707A1 (en) 2011-11-19 2012-11-19 Treatment of adrenal insufficiency

Publications (1)

Publication Number Publication Date
HK1194005A1 true HK1194005A1 (zh) 2014-10-10

Family

ID=45475414

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14107519.1A HK1194005A1 (zh) 2011-11-19 2014-07-23 腎上腺功能不全的治療

Country Status (22)

Country Link
US (2) US9675559B2 (zh)
EP (1) EP2780003B1 (zh)
JP (2) JP6228125B2 (zh)
KR (1) KR101995999B1 (zh)
AU (1) AU2012338583B2 (zh)
BR (1) BR112014011745B1 (zh)
CA (1) CA2854717C (zh)
CY (1) CY1123130T1 (zh)
DK (1) DK2780003T3 (zh)
ES (1) ES2782503T3 (zh)
GB (2) GB201119985D0 (zh)
HK (1) HK1194005A1 (zh)
HR (1) HRP20200452T1 (zh)
HU (1) HUE048445T2 (zh)
IL (1) IL232065A (zh)
LT (1) LT2780003T (zh)
PL (1) PL2780003T3 (zh)
PT (1) PT2780003T (zh)
RS (1) RS60132B1 (zh)
SI (1) SI2780003T1 (zh)
WO (1) WO2013072707A1 (zh)
ZA (1) ZA201403462B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201119985D0 (en) 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
GB201308933D0 (en) 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition
WO2019221483A1 (ko) 2018-05-14 2019-11-21 주식회사 엘지화학 화합물 및 이를 포함하는 유기 발광 소자

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183662A (en) * 1990-08-30 1993-02-02 Senju Pharmaceutical Co., Ltd. Controlled drug release composition
CA2244421A1 (en) * 1996-01-16 1997-07-24 Advanced Polymer Systems, Inc. Topical delivery of drugs to the lower gastrointestinal tract
TR199901564T2 (xx) * 1997-01-06 1999-09-21 Pfizer Inc. H�zl� ��z�lebilen ve tat-maskesi sa�layan dozaj ispen�iyari formu.
SE0401031D0 (sv) 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
MXPA06012088A (es) 2004-04-22 2007-08-14 Duocort Ab Composiciones farmaceuticas para terapia aguda con glucocorticoides.
RU2382637C2 (ru) 2004-04-30 2010-02-27 Астеллас Фарма Инк. Фармацевтическая композиция для перорального введения в форме частиц с рассчитанным временем высвобождения и быстро распадающиеся таблетки, содержащие указанную композицию
WO2006026504A2 (en) 2004-08-27 2006-03-09 Spherics, Inc. Mucoadhesive oral formulations of high permeability, high solubility drugs
EP2120868A4 (en) 2007-04-11 2010-08-25 Perrigo Israel Phamaceuticals LOW-DOSED MOMETASON FORMULATIONS
EP2161036B1 (en) * 2007-06-06 2014-12-10 Asahi Kasei Chemicals Corporation Cellulose fine core particle, and method for production thereof
GB0817120D0 (en) 2008-09-19 2008-10-29 Diurnal Ltd Treatment of adrenal insufficiency
EP2416783B1 (en) 2009-04-07 2018-11-07 Shire Viropharma Incorporated Improved glucocorticoid therapy
JP5758899B2 (ja) * 2009-09-17 2015-08-05 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 活性物質を含有するコーティングにより被覆されたペレット
BR112012029466A2 (pt) 2010-05-20 2017-03-01 Duocort Phama Ab "composição de glicocorticoide, método melhorado para tratar a deficiência de glicocorticoide, e, método para dar origem a uma dosagem individualizada de glicocorticoides"
GB201119985D0 (en) 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
GB201308933D0 (en) 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition

Also Published As

Publication number Publication date
KR20140108638A (ko) 2014-09-12
EP2780003B1 (en) 2020-02-19
KR101995999B1 (ko) 2019-07-03
JP6228125B2 (ja) 2017-11-08
ES2782503T3 (es) 2020-09-15
PL2780003T3 (pl) 2020-06-29
PT2780003T (pt) 2020-04-08
CY1123130T1 (el) 2021-10-29
SI2780003T1 (sl) 2020-07-31
WO2013072707A1 (en) 2013-05-23
DK2780003T3 (da) 2020-03-30
AU2012338583B2 (en) 2017-01-19
CA2854717C (en) 2020-12-08
IL232065A (en) 2016-04-21
AU2012338583A1 (en) 2014-05-01
US20140287052A1 (en) 2014-09-25
BR112014011745B1 (pt) 2022-04-05
LT2780003T (lt) 2020-04-27
GB2509663A (en) 2014-07-09
EP2780003A1 (en) 2014-09-24
JP2017200942A (ja) 2017-11-09
GB201407380D0 (en) 2014-06-11
JP2014533679A (ja) 2014-12-15
US9675559B2 (en) 2017-06-13
IL232065A0 (en) 2014-05-28
CA2854717A1 (en) 2013-05-23
US20170202856A1 (en) 2017-07-20
HUE048445T2 (hu) 2020-08-28
US9717740B1 (en) 2017-08-01
GB201119985D0 (en) 2012-01-04
BR112014011745A2 (pt) 2017-05-30
GB2509663B (en) 2015-01-07
RS60132B1 (sr) 2020-05-29
ZA201403462B (en) 2016-05-25
HRP20200452T1 (hr) 2020-10-16

Similar Documents

Publication Publication Date Title
EP2723384A4 (en) TREATMENT OF PROTEINOPATHIES
EP2773754A4 (en) Methods of Treatment
GB201110095D0 (en) Method of treatment
EP2717855A4 (en) PROCESSING METHODS
HK1198812A1 (zh) 鼻炎的治療
HK1199015A1 (zh) 炎症的治療
GB201119774D0 (en) IBS treatment
EP2709665A4 (en) TREATMENT OF PSORIASIS
EP2672963A4 (en) METHOD FOR THE TREATMENT OF MELANOMA
HK1199737A1 (zh) 煤炭加工
HK1194005A1 (zh) 腎上腺功能不全的治療
SG2014013585A (en) Method for bonding of substrates
IL231143A0 (en) Treatment of rhinitis
EP2791324A4 (en) PROCESSING METHOD
GB201102798D0 (en) Treatment of adrenal insufficiency
GB201100650D0 (en) Treatment of adrenal insufficiency
GB201121044D0 (en) Treatment of solutions
GB201110602D0 (en) Methods of treatment
GB201109737D0 (en) Methods of treatment
GB201111530D0 (en) Method of treatment
GB201109509D0 (en) Method of treatment
GB201109266D0 (en) Method of treatment
GB201103044D0 (en) Method of treatment
GB201100651D0 (en) Treatment of inflammation
GB201121207D0 (en) IBS treatment